Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MACH trial: Meclizine hydrochloride in pediatric achondroplasia
jRCT2041230001Completed
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of meclizine in achondroplasia (ACH). Primary endpoints: Safety: adverse events over 7 months and Growth rate. Started May 2023; status: completed.
02
Drugs
meclizine
03
Conditions
achondroplasia (ACH)
Beyond the preview
Go deeper on jRCT2041230001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2041230001.